Skip to content

FibroBiologics, Inc.

FBLG Nasdaq SEC CIK 1958777

Follow FibroBiologics Weekly email: filings, results, news

News

4 stories filed under FibroBiologics

Markets

Thread · 4 stories

FibroBiologics, Inc. (FBLG) Discusses Strategy and Clinical Progress in Fibroblast-Based Cell Therapies for Chronic Diseases Transcript

Markets 2 d ago

FibroBiologics appoints Leigh Steinberg to board

Markets 31 d ago

FibroBiologics reports cartilage repair in animal study

Markets 37 d ago

FibroBiologics receives patent for islet transplant method

Markets 44 d ago

Profile

Headquarters: HOUSTON, TX, United States
Sector: Healthcare
Industry: Pharmaceutical Preparations

Peers

Where this page comes from

Profile · SEC EDGAR

News · 4 stories clustered from the RSS aggregator